Recent 8-K filings for RIGL

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 12, 2026 21:24 UTC other_material item 1.01

  Rigel licenses VEPPANU (vepdegestrant) from Arvinas/Pfizer; $70M upfront plus milestones

source · RIGL on sec.gov